Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma

Biochemical and Biophysical Research Communications

Volumn 361, Issue 3, 2007, Pages 615-620

  Choi, Jee Hye ^a   Park, Soo Hyun ^a   Park, Jina ^a   Park, Borae G ^a   Cha, Seong Jae ^a   Kong, Kwang Hoon ^a   Lee, Kwang Ho ^a   Park, Ae Ja ^a  

^a Chung Ang University   (South Korea)

Author keywords

AP2; Colorectal carcinoma; CpG; DNA methylation; Epigenetic regulation; hTERT; Malignant progression; Promoter; Telomerase

Indexed keywords

ARTICLE; CANCER GROWTH; CELL AGING; CELL IMMORTALIZATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; TRANSCRIPTION REGULATION;

BINDING SITES; CARCINOMA; COLORECTAL NEOPLASMS; CPG ISLANDS; CYTOSINE; DNA METHYLATION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA; SITE-SPECIFIC DNA METHYLTRANSFERASE (CYTOSINE-SPECIFIC); TELOMERASE;

EID: 34547807674     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.07.051     Document Type: Article

References (21)

1. Collins K., and Mitchell J.R. Telomerase in the human organism. Oncogene 21 (2002) 564-579
2. Boldrini L., Faviana P., Gisfredi S., Zucconi Y., Di Quirico D., Donati V., Berti P., Spisni R., Galleri D., Materazzi G., Basolo F., Miccoli P., Pingitore R., and Fontanini G. Evaluation of telomerase in the development and progression of colon cancer. Int. J. Mol. Med. 10 (2002) 589-592
3. Engelhardt M., Drullinsky P., Guillem J., and Moore M.A. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3 (1997) 1931-1941
4. Niiyama H., Mizumoto K., Sato N., Nagai E., Mibu R., Fukui T., Kinoshita M., and Tanaka M. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Am. J. Gastroenterol. 96 (2001) 1895-1900
5. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., and Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90 (1997) 785-795
6. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
7. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., et al. The RNA component of human telomerase. Science 269 (1995) 1236-1241
8. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., and Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18 (1998) 65-68
9. Chiu C.P., and Harley C.B. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc. Soc. Exp. Biol. Med. 214 (1997) 99-106
10. Ng H.H., and Bird A. DNA methylation and chromatin modification. Curr. Opin. Genet. Dev. 9 (1999) 158-163
11. Warnecke P.M., and Bestor T.H. Cytosine methylation and human cancer. Curr. Opin. Oncol. 12 (2000) 68-73
12. Guilleret I., and Benhattar J. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. Biochem. Biophys. Res. Commun. 325 (2004) 1037-1043
13. Clement G., Braunschweig R., Pasquier N., Bosman F.T., and Benhattar J. Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformation. J. Pathol. 208 (2006) 100-107
14. Dessain S.K., Yu H., Reddel R.R., Beijersbergen R.L., and Weinberg R.A. Methylation of the human telomerase gene CpG island. Cancer Res. 60 (2000) 537-541
15. Clement G., and Benhattar J. A methylation sensitive dot blot assay (MS-DBA) for the quantitative analysis of DNA methylation in clinical samples. J. Clin. Pathol. 58 (2005) 155-158
16. Widschwendter A., Muller H.M., Fiegl H., Ivarsson L., Wiedemair A., Muller-Holzner E., Goebel G., Marth C., and Widschwendter M. DNA methylation in serum and tumors of cervical cancer patients. Clin. Cancer Res. 10 (2004) 565-571
17. Liu J.L., Ge L.Y., and Zhang G.N. Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma. World J. Gastroenterol. 12 (2006) 465-467
18. Renaud S., Loukinov D., Bosman F.T., Lobanenkov V., and Benhattar J. CTCF binds the proximal exonic region of hTERT and inhibits its transcription. Nucleic Acids Res. 33 (2005) 6850-6860
19. Wick M., Zubov D., and Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232 (1999) 97-106
20. Oh S., Song Y.H., Yim J., and Kim T.K. Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19 (2000) 1485-1490
21. Gunes C., Lichtsteiner S., Vasserot A.P., and Englert C. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60 (2000) 2116-2121